Ignite Creation Date:
2025-12-24 @ 10:58 PM
Ignite Modification Date:
2025-12-25 @ 8:27 PM
Study NCT ID:
NCT05217069
Status:
COMPLETED
Last Update Posted:
2025-04-16
First Post:
2019-01-22
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
FOLFIRI + Cetuximab + Avelumab RAS Wild-type CRC
Sponsor:
Ludwig-Maximilians - University of Munich
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-09-27
Start Date Type:
ACTUAL
Primary Completion Date:
2023-09-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-10-18
Completion Date Type:
ACTUAL
First Submit Date:
2019-01-22
First Submit QC Date:
None
Study First Post Date:
2022-02-01
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-04-11
Last Update Post Date:
2025-04-16
Last Update Post Date Type:
ACTUAL